ChartRow logo
Share this page
VRDN
$19.03-2.71%
as of close, Oct 16, 2026
☾ AH $19.03 -2.71%
PeersMRNALLYMDTUNHJNJTMO

Viridian Therapeutics Inc. trailing returns

Viridian Therapeutics Inc.'s 10-year return is -15.8% a year (CAGR) (-82.0% cumulative). How Viridian Therapeutics Inc. (VRDN) has performed over the last day, week, month and year, over 5 and 10 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-2.7%+0.0%-2.7%—
5 days+2.0%+0.0%+2.0%-2.7%Oct 16
1 month-15.2%+0.0%-15.2%-18.8%Oct 6
YTD-38.8%+0.0%-38.8%-60.6%Apr 29
1 year-17.3%+0.0%-17.3%-60.6%Apr 2026
5 years+2.2%+0.0%+2.2%+11.5%-70.7%Apr 2025
10 years-15.8%+0.0%-15.8%-82.0%-97.9%Mar 2020
Since inception (2014)-31.6%+0.0%-31.6%-99.1%-99.7%Mar 2020

Growth of VRDN#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+2.2%/year · +11.5%
  • 10 years-15.8%/year · -82.0%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in VRDN's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Viridian Therapeutics Inc.'s 10-year return?
Over the last 10 years, Viridian Therapeutics Inc. (VRDN) returned about -15.8% a year annualized (-82.0% cumulative total return).
What is Viridian Therapeutics Inc.'s return since inception?
Since 2014, Viridian Therapeutics Inc. (VRDN) has compounded at about -31.6% a year — -99.1% in total.

More on Viridian Therapeutics Inc.